Related Experiment Video
Updated: Jul 2, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Pulmonary Tuberculosis following Chemotherapy for Metastatic Testicular Germ Cell Tumor: Possible Reactivation of
Dika Safari Ramadhan1,2, Isnin Anang Marhana1,2
1Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
Abstract:
Testicular germ cell tumors (TGCTs) are the most common solid malignancies in young adult men. Advanced disease requiring systemic chemotherapy may lead to immunosuppression and increase vulnerability to opportunistic infections, particularly in tuberculosis (TB)-endemic regions. Coexistence of visceral metastases and infectious comorbidities such as pulmonary TB can substantially complicate diagnostic evaluation and therapeutic decision-making. Latent TB infection (LTBI) reactivation following chemotherapy is a recognized but likely underreported complication in patients with solid tumors, posing additional clinical challenges. A 41-year-old male with a history of mixed TGCT who had undergone radical orchiectomy followed by platinum-based chemotherapy, presented with chronic cough, weight loss, and neurological symptoms. Imaging revealed a large pulmonary mass and a cerebral lesion consistent with metastases. Further evaluation confirmed pulmonary and brain metastases of TGCT origin. Pulmonary TB was bacteriologically confirmed by bronchoalveolar lavage GeneXpert. He received anti-TB therapy, supportive neurological treatment, and delayed neurosurgery after stabilization. Temporal association between prior chemotherapy, significant immunosuppression, and active TB development raised the suspicion of LTBI reactivation. He was discharged in the stable condition with plans for oncologic restaging and second-line chemotherapy. This case highlights the diagnostic and therapeutic challenges posed by the coexistence of metastatic TGCT and pulmonary TB. In TB-endemic settings, clinicians should maintain a high index of suspicion for TB in immunocompromised cancer patients presenting with pulmonary lesions. Multidisciplinary management and careful timing of oncologic and anti-TB treatments are essential to optimize the outcomes, and possible reactivation of LTBI should be considered following chemotherapy.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...